Our investigation shows that ATP_CD4 may potentially serve as marker to discriminate between patients with better post-AKI outcome (complete renal recovery) from patients with partial recovery of renal function including persistent need for dialysis, and from patients with sepsis-associated death. At 48 hours after inclusion into the study, ATP_CD4 tended to be lower in concentration in comparison to the two other groups. Nevertheless, differences were only close to the level of significance, most likely as a result of the limited number of subjects. We extrapolated the number of patients necessary for detecting a significant difference. A minimum total number of 159 individuals with 53 subjects per individual group would have to be included into the investigation. Such expanded study is being initiated at the moment.
Urinary NGAL was useful for differentiating the severity of acute renal dysfunction. It gradually increased with progression of AKI from stage 1 to 3 according to the AKIN criteria. It still remains a fundamental goal to identify new marker molecules of acute renal damage, as they are useful for diagnosing AKI at an early stage, and should also aid with the prediction of both renal and overall outcome of patients with AKI. Serum creatinine has been used for more than 50 years now [
14]. Although a number of new promising candidates were identified in recent years, including Cystatin C [
13,
15], NGAL [
16], KIM-1 [
17], none of them have shown to be superior to the others in terms of early AKI detection. In addition, predicting the
prognosis of AKI is still very difficult. This results from the fact that most of the diagnostic markers available today are
eliminated by the kidney, but do not indicate processes involved in tissue regeneration and repair. Septic AKI significantly results from renal hypoperfusion causing damage of the tubular epithelium. Other consequences include intrarenal inflammation and peritubular microvasculopathy; both significantly modify dynamics of postischemic tissue regeneration [
5]. Nevertheless, indirect methods for monitoring tissue damage and repair are still lacking. Postischemic intrarenal inflammation is initiated by ischemia-induced release of proinflammatory cytokines by tubular epithelial and vascular endothelial cells, respectively [
18]. Increased IL-6 serum levels have been shown to predict mortality in AKI [
19]. In order to monitor activity of T cells in sepsis, a larger cohort of sepsis patients was analyzed for ATP concentrations in the cells (ATP_CD4) [
5]. The investigation showed higher ATP_CD4 in survivors as compared to non-survivors. Although one may conclude that higher ATP_CD4 indicate increased cell competence, it is still not possible to draw any definite conclusions about the relevance of this finding in the process of self-repair. Our study, on the other hand, revealed lower ATP_CD4 levels in patients with complete renal recovery after sepsis-associated AKI. This observation is in line with more recent data about ATP_CD4 in renal transplant recipients. In this particular study, increased ATP levels predicted acute renal allograft rejection [
20]. Therefore, lower ATP_CD4 levels may indicate a lower risk for immune-mediated kidney damage ultimately promoting faster recovery from sepsis-associated AKI. However, at this point it is too early to establish ATP_CD4 as new diagnostic parameter in sepsis-associated AKI or even to draw definite conclusions about its role in AKI risk prediction. Further studies must be conducted to confirm the promising results of the current investigation. Particular interest will be related to additional time points of ATP_CD4 analysis. It needs to be determined whether ATP_CD4 concentration changes very early, for instance before sepsis can even be diagnosed. Thus, patients with increased risk for developing sepsis (e.g. chemotherapy, other immunosuppressive drugs, diabetes with severe non-septic infection) will be monitored as well. It should also be mentioned that the chronic uremic milieu in CKD may modulate ATP_CD4 in a way that dynamic alterations of ATP content cannot truly be compared with alterations seen in patients without preexisting CKD. That aspect would also have to be considered in further studies. Finally, a more detailed analysis of plasma NGAL levels is also needed in order to helpidentify patients with increased risk for CKD after AKI.